Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …

Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remain a
clinical challenge due to limited treatment options. Recently, cefiderocol, a novel …

A total of 199 Gram-negative bacterial isolates from urinary tract infections and 162 from
bloodstream infections were collected from 12 healthcare systems throughout the United …

Background The treatment of carbapenem-resistant Acinetobacter baumannii/calcoaceticus
complex (CRAB) presents significant treatment challenges. Methods We report the case of a …

Owing to the global health crisis of resistant pathogenic infections, researchers are
emphasizing the importance of novel prevention and control strategies. Existing …

The rapid emergence of multi-drug resistant Gram-negative pathogens has driven the
introduction of novel β-lactam combination agents (BLCs) to the antibiotic market …

Antimicrobial resistance is a global threat that requires urgent attention to slow the spread of
resistant pathogens. The United States Centers for Disease Control and Prevention (CDC) …

Background: Sulbactam-durlobactam (SUL-DUR) has been tested in vitro for its ability to
generate resistance in clinical isolates of Acinetobacter species. According to prior studies …

La visita diaria por parte de un equipo de enfermedades infecciosas en un hospital
asistencial docente del sistema público está enfocada principalmente en el ejercicio …

La resistencia antibiótica, con Acinetobacter baumannii y Enterobacter cloacae complex
(ECC) como microorganismos clave, constituye una causa importante de morbimortalidad a …